首页 > 市场调查报告书 > 医疗设备

体外诊断癌症癌症诊断

市场调查报告书

商品编码

1547694

全球前列腺癌诊断市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Prostate Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球前列腺癌诊断市场需求预计将从 2023 年的 91.3 亿美元达到近 165.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.83%。

前列腺癌是男性最常见的癌症类型之一。这种癌症出现在男性前列腺的一个核桃形小腺体中，该腺体产生滋养和运输精子的精液。健康从业者会进行测试来分析和理解其严重性，并了解恶性生长是否已从起始部位扩散到身体的其他部位。医生也可能会进行测试来了解哪种治疗方法最有效。大多数前列腺癌是透过 PSA 测试、CTC 测试、免疫组织化学、直肠指检、影像学测试和 PCA3 测试筛检而首次发现的。

市场动态

全球前列腺癌盛行率的上升正在推动全球前列腺癌诊断市场的发展。摄护腺癌是全球第五大死因，也是男性第二常见的癌症诊断。根据GLOBOCAN估计，2018年全球新增摄护腺癌病例1,276,106例，其中已开发国家的负担较高。全球盛行率的差异反映了诊断检测使用的差异。然而，农村地区缺乏意识、高昂的诊断成本和医疗设施不足阻碍了市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球前列腺癌诊断市场的每个细分市场进行了包容性评估。前列腺癌诊断产业的成长和趋势为本研究提供了整体方法。

市场区隔

前列腺癌诊断市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按测试类型

初步测试（PSA测试、免费PSA测试、总PSA测试、其他初步测试）
验证性测试（Pca3 测试、经直肠超音波检查、活检测试）

按类型展望

腺癌
间质细胞癌
其他

按最终用途

医院
门诊设施
居家护理
研究与製造

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲前列腺癌诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。摄护腺癌诊断市场的主要参与者包括 MDx Health、Myriad Genetics Inc.、Abbott Laboratories、F. Hoffman-La Roche AG、Bayer AG、Siemens Healthcare GmbH、OPKO Health Inc.、Genomic Health.、辉瑞公司。格局的整体看法，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：前列腺癌诊断公司的竞争格局

前列腺癌诊断市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
MDx Health

公司概况
公司收入
产品
最新动态

Myriad Genetics Inc.

公司概况
公司收入
产品
最新动态

Abbott Laboratories

公司概况
公司收入
产品
最新动态

F. Hoffman-La Roche AG

公司概况
公司收入
产品
最新动态

Bayer AG

公司概况
公司收入
产品
最新动态

Siemens Healthcare GmbH

公司概况
公司收入
产品
最新动态

OPKO Health Inc.

公司概况
公司收入
产品
最新动态

Genomic Health.

公司概况
公司收入
产品
最新动态

Pfizer Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213873

The global demand for Prostate Cancer Diagnostics Market is presumed to reach the market size of nearly USD 16.55 Billion by 2032 from USD 9.13 Billion in 2023 with a CAGR of 6.83% under the study period 2024-2032.

Prostate cancer is among the most frequent cancer type in the male. This cancer appears in the prostate in a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. Health practitioners do tests to analyze and comprehend the seriousness and learn if malignant growth has spread to other body locations from where it started. Doctors may also do tests to know which treatments could work best. Most prostate cancers are first found due to screening with PSA tests, CTC tests, immunohistochemistry, digital rectal exam, imaging test, and PCA3 test.

MARKET DYNAMICS

The rising prevalence of prostate cancer worldwide is driving the global prostate cancer diagnostics market. Prostate cancer is the fifth dominating cause of death worldwide and the second most frequent cancer diagnosis made in men. According to GLOBOCAN estimates, in 2018, 1,276,106 new prostate cancer cases were reported globally, with a higher burden in the developed countries. Differences in the prevalence rates worldwide reflect differences in the use of diagnostic testing. However, lack of awareness, high cost of diagnosis, and inadequate healthcare facilities in rural areas hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Prostate Cancer Diagnostics. The growth and trends of Prostate Cancer Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Prostate Cancer Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests)
Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test)

By Type Outlook

Adenocarcinoma
Interstitial Cell Carcinoma
Other

By End Use

Hospitals
Outpatient Facilities
Home Care
Research & Manufacturing

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Prostate Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Prostate Cancer Diagnostics market include MDx Health, Myriad Genetics Inc., Abbott Laboratories, F. Hoffman-La Roche AG, Bayer AG, Siemens Healthcare GmbH, OPKO Health Inc., Genomic Health., Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROSTATE CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By Type Outlook
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

5.1. Overview By Test Type
5.2. Historical and Forecast Data
5.3. Analysis By Test Type
5.4. Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests) Historic and Forecast Sales By Regions
5.5. Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test) Historic and Forecast Sales By Regions

6. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY TYPE OUTLOOK

6.1. Overview By Type Outlook
6.2. Historical and Forecast Data
6.3. Analysis By Type Outlook
6.4. Adenocarcinoma Historic and Forecast Sales By Regions
6.5. Interstitial Cell Carcinoma Historic and Forecast Sales By Regions
6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Outpatient Facilities Historic and Forecast Sales By Regions
7.6. Home Care Historic and Forecast Sales By Regions
7.7. Research & Manufacturing Historic and Forecast Sales By Regions

8. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PROSTATE CANCER DIAGNOSTICS COMPANIES

9.1. Prostate Cancer Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PROSTATE CANCER DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. MDx Health
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Myriad Genetics Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Abbott Laboratories
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. F. Hoffman-La Roche AG
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Bayer AG
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Siemens Healthcare GmbH
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. OPKO Health Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Genomic Health.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Pfizer Inc
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Test Type (USD MN)
Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests) Market Sales By Geography (USD MN)
Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test) Market Sales By Geography (USD MN)
Analysis By Type Outlook (USD MN)
Adenocarcinoma Market Sales By Geography (USD MN)
Interstitial Cell Carcinoma Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Analysis By End Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Outpatient Facilities Market Sales By Geography (USD MN)
Home Care Market Sales By Geography (USD MN)
Research & Manufacturing Market Sales By Geography (USD MN)
Global Prostate Cancer Diagnostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Prostate Cancer Diagnostics Report
Market Research Process
Market Research Methodology
Global Prostate Cancer Diagnostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Test Type
Market Attractiveness Analysis By Type Outlook
Market Attractiveness Analysis By End Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Test Type (USD MN)
Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests) Market Sales By Geography (USD MN)
Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test) Market Sales By Geography (USD MN)
Global Market Analysis By Type Outlook (USD MN)
Adenocarcinoma Market Sales By Geography (USD MN)
Interstitial Cell Carcinoma Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Global Market Analysis By End Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Outpatient Facilities Market Sales By Geography (USD MN)
Home Care Market Sales By Geography (USD MN)
Research & Manufacturing Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis